School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, West Bengal, India.
Fertil Steril. 2011 May;95(6):1961-5. doi: 10.1016/j.fertnstert.2011.01.148. Epub 2011 Feb 21.
To compare the efficacy of oral dydrogesterone with that of micronized vaginal P gel and micronized P capsule for luteal supplementation.
Prospective, randomized clinical study.
Institute of Reproductive Medicine, Kolkata, India.
PATIENT(S): A total of 1,373 infertile women undergoing IVF participated.
INTERVENTION(S): Micronized P gel, P capsule, and oral dydrogesterone were administered for luteal support and compared.
MAIN OUTCOME MEASURE(S): Demographic profile and pregnancy and miscarriage rates.
RESULT(S): The overall pregnancy rate and miscarriage rate were comparable among the three groups.
CONCLUSION(S): Oral dydrogesterone seems to be a promising drug for luteal support in woman undergoing IVF.
比较口服地屈孕酮与微粒化阴道 P 凝胶和微粒化 P 胶囊用于黄体支持的疗效。
前瞻性、随机临床研究。
印度加尔各答生殖医学研究所。
共有 1373 名接受试管婴儿治疗的不孕妇女参与。
给予微粒化 P 凝胶、P 胶囊和口服地屈孕酮进行黄体支持,并进行比较。
人口统计学特征和妊娠及流产率。
三组的总体妊娠率和流产率相似。
口服地屈孕酮似乎是一种有前途的药物,可用于接受试管婴儿治疗的妇女的黄体支持。